American International Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,685
Closed -$99K 184
2024
Q1
$99K Sell
1,685
-25
-1% -$1.47K ﹤0.01% 2519
2023
Q4
$102K Sell
1,710
-23
-1% -$1.38K ﹤0.01% 2554
2023
Q3
$65.9K Sell
1,733
-121
-7% -$4.6K ﹤0.01% 2736
2023
Q2
$169K Sell
1,854
-43,407
-96% -$3.95M ﹤0.01% 2273
2023
Q1
$2.99M Buy
45,261
+900
+2% +$59.4K 0.02% 865
2022
Q4
$2.29M Sell
44,361
-161
-0.4% -$8.33K 0.02% 914
2022
Q3
$3.04M Buy
44,522
+1,964
+5% +$134K 0.02% 839
2022
Q2
$1.92M Buy
42,558
+3,742
+10% +$169K 0.01% 956
2022
Q1
$1.97M Buy
38,816
+828
+2% +$42.1K 0.01% 1025
2021
Q4
$1.8M Buy
37,988
+2,439
+7% +$115K 0.01% 1125
2021
Q3
$1.17M Sell
35,549
-845
-2% -$27.9K 0.01% 1352
2021
Q2
$2.3K Buy
36,394
+1,393
+4% +$88 0.01% 1057
2021
Q1
$1.5K Buy
35,001
+92
+0.3% +$4 0.01% 1264
2020
Q4
$2K Sell
34,909
-1,002
-3% -$57 0.01% 1078
2020
Q3
$1.08M Sell
35,911
-816
-2% -$24.6K 0.01% 1208
2020
Q2
$1.2M Buy
36,727
+2,850
+8% +$93.1K 0.01% 1134
2020
Q1
$908K Buy
33,877
+3,297
+11% +$88.4K 0.01% 1153
2019
Q4
$936K Buy
30,580
+59
+0.2% +$1.81K ﹤0.01% 1369
2019
Q3
$735K Sell
30,521
-213
-0.7% -$5.13K ﹤0.01% 1463
2019
Q2
$779K Buy
30,734
+7,704
+33% +$195K ﹤0.01% 1459
2019
Q1
$449K Sell
23,030
-747
-3% -$14.6K ﹤0.01% 1773
2018
Q4
$314K Sell
23,777
-183
-0.8% -$2.42K ﹤0.01% 1920
2018
Q3
$426K Buy
23,960
+432
+2% +$7.68K ﹤0.01% 1987
2018
Q2
$518K Buy
23,528
+16,457
+233% +$362K ﹤0.01% 1813
2018
Q1
$156K Sell
7,071
-221
-3% -$4.88K ﹤0.01% 2401
2017
Q4
$158K Buy
+7,292
New +$158K ﹤0.01% 2461